Parean Biotechnologies is a pioneering service company dedicated to advancing preclinical and clinical programs in the field of oncology and immune related diseases.
Our comprehensive approach integrates an in-house wet lab (cytometry, cell sorting, libraries generation in bulk or single cell protocols) and a cutting-edge data science unit to drive innovation and foster transformative breakthroughs.
Key offerings includes:
- Deep Immune Phenotyping Expertise: Acting as an interim research team, we provide unparalleled proficiency in deep immune phenotyping, with a focus on T-Cell, B-Cell, NK, and other immune cell subsets.
- End-to-End Immune Cells Analysis: From diverse biologic samples (blood or tissue), we deliver comprehensive immune cells analysis services, encompassing biostatistical analysis, in both bulk and single-cell settings. Our capabilities are further enhanced by multi-omics data generation.
- User-Friendly Data Visualization: Parean Biotechnologies offers a dynamic and user-friendly data visualization tool, ensuring accessibility and clarity in interpreting complex immunological data.
- Experimental Protocol Design: We excel in designing experimental protocols tailored for deep immune phenotyping, ensuring the precision and reliability of the analytical process.
- Data Science Solutions: Leveraging our expertise, we provide advanced Data Science services on existing omics data, including immune phenotyping, transcriptomics, microbiota, and more.
- Research Programs in Immuno-Oncology: Our internal research programs focus on immuno-oncology, utilizing cutting-edge techniques and machine learning approaches to develop new tools for biotech and pharma drug discovery.
Parean Biotechnologies is committed to driving advancements in immuno-oncology and immune related diseases, through a holistic and integrated approach, offering unparalleled insights and solutions for the benefit of researchers, clinicians, and biotech / pharma industry
-
Secteur
-
Biotechnologie
-
Taille de l’entreprise
-
2-10 employés
-
Siège social
-
Saint-Malo
-
Type
-
Société civile/Société commerciale/Autres types de sociétés
-
Fondée en
-
2020
-
Domaines
-
Immune System, RNA Sequencing, TCR Sequencing, Omics DataScience, Immuno-Oncology, Clinical Data Integration, Complex Biological Analysis, Transcriptomics, Immunogenicity, DataScience, Artificial Intelligence, CarT Cell, Computational Biology, ImmunoTherapy, Biomarkers et Signature